Former FDA Director Joins Provention Bio Board
Here is a brief preview of this blast: Yesterday, Provention Bio announced the appointment of John K. Jenkins, MD (pictured below) to the company's Board of Directors. Prior to Provention Bio, Jenkins worked at FDA for 25 years and served as Director of the Office of New Drugs for 15 years. Below, FENIX provides brief thoughts on Jenkins's appointment.